Brain signaling systems in the type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases
AO Shpakov, KV Derkach, LM Berstein - Future science OA, 2015 - Taylor & Francis
The changes in the brain signaling systems play an important role in etiology and
pathogenesis of Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MS), being a …
pathogenesis of Type 2 diabetes mellitus (T2DM) and metabolic syndrome (MS), being a …
The role of m6A and m6Am RNA modifications in the pathogenesis of diabetes mellitus
The rapidly develo** research field of epitranscriptomics has recently emerged into the
spotlight of researchers due to its vast regulatory effects on gene expression and thereby …
spotlight of researchers due to its vast regulatory effects on gene expression and thereby …
FTO Genotype and Type 2 Diabetes Mellitus: Spatial Analysis and Meta-Analysis of 62 Case-Control Studies from Different Regions
Y Yang, B Liu, W ** type 2 diabetes mellitus in Jordanian population
Background Several genome-wide association studies (GWAS) have identified the single
nucleotide polymorphism (SNP) rs13266634 in the Solute carrier family 30 member 8 …
nucleotide polymorphism (SNP) rs13266634 in the Solute carrier family 30 member 8 …
[HTML][HTML] Assessment of the environmental and genetic factors influencing prevalence of metabolic syndrome in Saudi Arabia
IM Gosadi - Saudi medical journal, 2016 - ncbi.nlm.nih.gov
Metabolic syndrome (MS) is a combination of factors that increases the risk of cardiovascular
atherosclerotic diseases including diabetes, obesity, dyslipidemia, and high blood pressure …
atherosclerotic diseases including diabetes, obesity, dyslipidemia, and high blood pressure …
The Effect Sizes of PPARγ rs1801282, FTO rs9939609, and MC4R rs2229616 Variants on Type 2 Diabetes Mellitus Risk among the Western Saudi Population: A …
Type 2 diabetes mellitus (T2DM) is a common polygenic disease with associated
comorbidities. Obesity is a major risk factor for the development of T2DM. The aim of this …
comorbidities. Obesity is a major risk factor for the development of T2DM. The aim of this …